SWK Holdings to Participate in Lake Street Capital's 6th Annual Best Ideas Growth Conference "BIG6"

Rhea-AI Summary

SWK Holdings Corporation (Nasdaq: SWKH) announced participation in Lake Street Capital's 6th Annual Best Ideas Growth Conference 'BIG6' on September 14, 2022, in New York City. President and Interim CEO, Jody Staggs, will conduct one-on-one meetings with investors to discuss SWK's business strategy, recent achievements, and future milestones. SWK specializes in providing non-dilutive financing to small- and mid-sized healthcare companies, with funding typically ranging from $5 million to $25 million. This participation aims to enhance visibility and attract potential investors.

DALLAS, Sept. 7, 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced that Jody Staggs, President and Interim CEO of SWK Holdings, will participate in Lake Street Capital's 6^th Annual Best Ideas Growth Conference "BIG6" being held September 14, 2022 in New York City.

During the conference, Mr. Staggs will conduct one-on-one meetings with registered investors, showcasing SWK Holdings' business and investment strategy, recent corporate achievements, and anticipated milestones.

Details of the conference are as follows:

Event: Lake Street Capital's 6th Annual Best Ideas Growth Conference "BIG6"

Date: September 14, 2022

Location: The Yale Club, 50 Vanderbilt Ave, New York, NY

About SWK Holdings Corporation

SWK Holdings Corporation is a life science focused specialty finance company partnering with small- and mid-sized commercial-stage healthcare companies. SWK provides non-dilutive financing to fuel the development and commercialization of life-saving and life-enhancing medical technologies and products. SWK's unique financing structures provide flexible financing solutions at an attractive cost of capital to create long-term value for all SWK stakeholders. SWK's solutions include structured debt, traditional royalty monetization, synthetic royalty transactions, and asset purchases, and typically range in size from $5.0 million to $25.0 million. SWK also owns Enteris BioPharma, whose Peptelligence^® and ProPerma^® drug delivery technologies create oral formulations of peptide-based and BCS class II, III, and IV small molecules. With Enteris, SWK has the opportunity to grow its finance portfolio by actively creating a wholly-owned portfolio of milestones and royalties through licensing activities. Additional information on the life science finance market is available on the Company's website at www.swkhold.com.

View original content:https://www.prnewswire.com/news-releases/swk-holdings-to-participate-in-lake-street-capitals-6th-annual-best-ideas-growth-conference-big6-301618990.html

SOURCE SWK Holdings Corporation

FAQ

What is the date of the Lake Street Capital BIG6 conference for SWK Holdings?

The Lake Street Capital's 6th Annual Best Ideas Growth Conference 'BIG6' is on September 14, 2022.

Who from SWK Holdings will participate in the BIG6 conference?

Jody Staggs, President and Interim CEO of SWK Holdings, will participate in the conference.

Where is the Lake Street Capital BIG6 conference being held?

The conference will be held at The Yale Club, 50 Vanderbilt Ave, New York, NY.

What does SWK Holdings specialize in?

SWK Holdings specializes in providing non-dilutive financing to small- and mid-sized commercial-stage healthcare companies.

What is the typical funding size offered by SWK Holdings?

SWK Holdings offers funding typically ranging from $5 million to $25 million.